These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15009136)

  • 1. Blockade of the NPY Y5 receptor potentiates circadian responses to light: complementary in vivo and in vitro studies.
    Yannielli PC; Brewer JM; Harrington ME
    Eur J Neurosci; 2004 Feb; 19(4):891-7. PubMed ID: 15009136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.
    Yannielli PC; Harrington ME
    J Neurosci; 2001 Jul; 21(14):5367-73. PubMed ID: 11438613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of circadian light induced phase advances and delays by neuropeptide Y and a neuropeptide Y Y1/Y5 receptor agonist.
    Lall GS; Biello SM
    Neuroscience; 2003; 119(2):611-8. PubMed ID: 12770573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y attenuates NMDA-induced phase shifts in the SCN of NPY Y1 receptor knockout mice in vitro.
    Soscia SJ; Harrington ME
    Brain Res; 2004 Oct; 1023(1):148-53. PubMed ID: 15364030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian control during the day and night: Role of neuropeptide Y Y5 receptors in the suprachiasmatic nucleus.
    Gamble KL; Ehlen JC; Albers HE
    Brain Res Bull; 2005 May; 65(6):513-9. PubMed ID: 15862923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y rapidly reduces Period 1 and Period 2 mRNA levels in the hamster suprachiasmatic nucleus.
    Fukuhara C; Brewer JM; Dirden JC; Bittman EL; Tosini G; Harrington ME
    Neurosci Lett; 2001 Nov; 314(3):119-22. PubMed ID: 11704298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes.
    Gribkoff VK; Pieschl RL; Wisialowski TA; van den Pol AN; Yocca FD
    J Neurosci; 1998 Apr; 18(8):3014-22. PubMed ID: 9526018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y applied in vitro can block the phase shifts induced by light in vivo.
    Yannielli PC; Harrington ME
    Neuroreport; 2000 May; 11(7):1587-91. PubMed ID: 10841381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptor.
    Huhman KL; Gillespie CF; Marvel CL; Albers HE
    Neuroreport; 1996 May; 7(7):1249-52. PubMed ID: 8817542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness.
    Huhman KL; Albers HE
    Peptides; 1994; 15(8):1475-8. PubMed ID: 7700850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y differentially suppresses per1 and per2 mRNA induced by light in the suprachiasmatic nuclei of the golden hamster.
    Brewer JM; Yannielli PC; Harrington ME
    J Biol Rhythms; 2002 Feb; 17(1):28-39. PubMed ID: 11837945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NPY opposes PACAP phase shifts via receptors different from those involved in NPY phase shifts.
    Harrington ME; Hoque S
    Neuroreport; 1997 Aug; 8(12):2677-80. PubMed ID: 9295099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian phase shifts to neuropeptide Y In vitro: cellular communication and signal transduction.
    Biello SM; Golombek DA; Schak KM; Harrington ME
    J Neurosci; 1997 Nov; 17(21):8468-75. PubMed ID: 9334419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y, GABA and circadian phase shifts to photic stimuli.
    Lall GS; Biello SM
    Neuroscience; 2003; 120(4):915-21. PubMed ID: 12927198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical effects of NPY in the suprachiasmatic nucleus.
    Gamble KL; Paul KN; Karom MC; Tosini G; Albers HE
    Eur J Neurosci; 2006 May; 23(9):2488-94. PubMed ID: 16706855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y and glutamate block each other's phase shifts in the suprachiasmatic nucleus in vitro.
    Biello SM; Golombek DA; Harrington ME
    Neuroscience; 1997 Apr; 77(4):1049-57. PubMed ID: 9130786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y phase shifts the circadian clock in vitro via a Y2 receptor.
    Golombek DA; Biello SM; Rendon RA; Harrington ME
    Neuroreport; 1996 May; 7(7):1315-9. PubMed ID: 8817557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y blocks light-induced phase advances but not delays of the circadian activity rhythm in hamsters.
    Weber ET; Rea MA
    Neurosci Lett; 1997 Aug; 231(3):159-62. PubMed ID: 9300646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the intrinsic regulation of neuropeptide Y release in the mammalian suprachiasmatic nucleus circadian clock.
    Glass JD; Guinn J; Kaur G; Francl JM
    Eur J Neurosci; 2010 Mar; 31(6):1117-26. PubMed ID: 20377624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the resetting effects of light on circadian rhythms of hamsters using serotonin and neuropeptide Y receptor antagonists.
    Lall GS; Harrington ME
    Neuroscience; 2006 Sep; 141(3):1545-52. PubMed ID: 16750888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.